Cardiometabolic Health Congress

SEPTEMBER 20, 2024

Hypertension is a condition that requires continuous monitoring, making it an ideal candidate for telehealth and digital health innovations. Why Telehealth is Essential for Hypertension For patients with hypertension, managing blood pressure outside of the office is crucial. Who Should Use Video Visits?

Blood Pressure 52

Blood Pressure Hypertension Lipid disorders Technology 52

DAIC

NOVEMBER 8, 2024

In approving the TPT, CMS created a distinct device category and code (C1736: Catheter Renal Denervation, Ultrasound) for Ultrasound Renal Denervation in recognition of the differentiated technology and procedure with the Paradise uRDN System.

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) 10. Scientists Suggest a New Method for Diagnosing Heart Diseases 6.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Circulation

NOVEMBER 11, 2024

Despite these technological strides, their adoption and sustained use remain limited to health-conscious individuals. The general populace, particularly those indifferent to health management, stands to miss out on the potential benefits of wearable technologies due to a lack of engagement. for 30-second data segments and 80.9%

Hypertension 45

Hypertension Diabetes Blood Pressure Technology 45

Wellnest

DECEMBER 18, 2023

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies. But what is resistant hypertension, and why does it require renal denervation?

Hypertension 52

Hypertension Blood Pressure Ablation Reimbursement 52

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

Hypertension Journal

JULY 16, 2024

Hypertension, Volume 82, Issue 1 , Page 26-35, January 1, 2025. The 2 critical underlying technologies in AI are used for supervised and unsupervised machine learning. AI can potentially improve hypertension diagnosis and treatment through remote patient monitoring and digital therapeutics.

Hypertension 40

Hypertension Blood Pressure Technology 40

GEMMS

APRIL 3, 2025

As patient expectations rise and technology advances, engaging patients effectively has never been more crucial to delivering top-tier care. In 2025, the demand for telehealth capabilities will only continue to grow, especially in managing chronic conditions like hypertension and heart disease. GEMMS ONE V7.8,

Technology 52

Technology Patient Care Education Innovation 52

DAIC

FEBRUARY 28, 2024

Use of these technologies has led to the analysis of electronic health records (EHRs) to understand various treatment effects, to compare the effectiveness of tests and interventions, and, more recently, to build prediction, classification and optimization models to help inform clinical decision-making. Implantable and Wearable Technologies.

Best Practices 111

Best Practices Technology Cardiovascular Disease Stroke 111

Journal of Cardiovascular Pharmacology

JUNE 3, 2024

However, its role on hypertensive renal injury has not been fully eucidated. A variety of technologies, including network pharmacology, RNA-sequencing, immunohistochemistry, and Western blotting were performed to investigate its underlying mechanisms. However, its role on hypertensive renal injury has not been fully eucidated.

Pharmacology 40

Pharmacology Hypertension Technology Article 40

Journal of the American Heart Association

MARCH 13, 2025

BackgroundResearch into the gutlung axis links gut microbiota to pulmonary artery hypertension (PAH). Our findings have implications for advancing gut microbiotabased PAH diagnostic technologies and targeted therapies. Journal of the American Heart Association, Ahead of Print.

Pulmonary 40

Pulmonary Hypertension Technology 40

Frontiers in Cardiovascular Medicine

FEBRUARY 22, 2024

Introduction Out-of-office blood pressure (BP) monitoring is increasingly valuable in the diagnosis and management of hypertension. With advances in wearable BP technologies, the ability to gain insight into BP outside of traditional centers of care has expanded greatly. Results Fifty participants, with a mean age of 44.5

Blood Pressure 64

Blood Pressure Technology Hypertension 64

Cardiometabolic Health Congress

JULY 25, 2024

Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C. Morris, MD as featured speakers; CMHC co-chairs Anne L.

Education 100

Education Innovation Risk Factors Obesity 100

Cardiometabolic Health Congress

AUGUST 2, 2024

The Omics Revolution: Powering Precision Nutrition Omics technologies form the backbone of genetically tailored nutrition, providing unprecedented insights into the molecular intricacies of human biology: Genomics : Unraveling the DNA blueprint to identify genetic variations that influence nutrient metabolism and dietary responses.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Hypertension Journal

NOVEMBER 17, 2023

Hypertension, Ahead of Print. BACKGROUND:Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension.

Hypertension 40

Hypertension Biomarkers Technology Research 40

DAIC

MAY 7, 2024

WMHs are related to chronic hypertension, diabetes, high cholesterol, and smoking, among other factors and conditions, and have been strongly related to cognitive impairment, but not extensively studied in the context of motor impairment. difficulty moving or using their arm for daily tasks), independent of CST damage. Toga, PhD. "We

Stroke 105

Stroke Strokes Research Public Health 105

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

GEMMS

SEPTEMBER 27, 2024

The Need for Personalization in Cardiology Cardiovascular health is inherently complex, with conditions ranging from hypertension to heart failure requiring specific treatment plans. Technological barriers , including outdated or incompatible systems. Regulatory issues that may limit how data can be shared between institutions.

Technology 52

Technology Genetic predisposition Patient Care Education 52

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

Circulation

NOVEMBER 11, 2024

Students conducted weekly Kessler psychological distress tests, HBP screenings and serve as a health technology coach. Each student monitored 2 hypertensive and psychological distressed patients.

Health Disparities 40

Health Disparities Cardiovascular Disease Education Hypertension 40

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundBlood pressure (BP) thresholds for diagnosing and managing hypertension vary for office, home, and ambulatory readings, and between guideline documents. Corresponding BP thresholds for office, home, and ambulatory measurements were determined using Deming regression.

Blood Pressure 40

Blood Pressure Hypertension Document Technology 40

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Circulation

NOVEMBER 11, 2024

This score ranges from 0-10; the lower its numerical value, the greater the microvascular impairment.Results:Twenty patients were included (61±10 years old, 85% males, 55% anterior AMI, 70% hypertension, 25% diabetes, 45% current smoker, all underwent primary PCI). The time between the two sublingual assessments was 188±31 days. The PBR [1.96±0.22µm

Myocardial Infarction 40

Myocardial Infarction Plaque Technology Diabetes 40

Vector Remote

MAY 9, 2023

How to Incorporate Remote Patient Monitoring Into Existing Workflows Remote patient monitoring (RPM) is a service under the telemedicine umbrella that uses specialized technology to track patient health data in real time, integrating care updates into clinic workflows as needed. The benefits of the technology are clear.

Heart Rhythm 52

Heart Rhythm Technology Blood Pressure Defibrillator 52

Vector Remote

MARCH 9, 2023

All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heart failure, and hypertension requires the ability to monitor a heart’s condition. Cardiac implantable devices are sophisticated technology that provide both therapy and diagnostics for patients with irregular heart rhythms.

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Recent technological advances, pathophysiology, and pharmacotherapy have contributed to a near-universal recognition of the overlap between ​cardiovascular, ​kidney, and ​metabolic diseases. MIRROR trial supports urate-lowering agent for gout and uncontrolled hypertension.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

MAY 8, 2024

Bioelectronic medicine scientists at The Feinstein Institutes for Medical Research used noninvasive, splenic focused ultrasound stimulation (sFUS) and found they can reduce inflammation and improve symptoms of pulmonary arterial hypertension (PAH).

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115

DAIC

FEBRUARY 7, 2024

milla1cf Wed, 02/07/2024 - 18:05 February 7, 2024 — The Consumer Technology Association ( CTA ) and the American College of Cardiology ( ACC ) are announcing the release of their second industry framework for the use of consumer cardiovascular technology solutions in the screening and diagnosis for cardiovascular conditions.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

Physiologically Speaking

JANUARY 26, 2024

Health and time have always been two sides of the same coin, but we haven’t had the technology to bridge them until now. Welcome to the Physiology Friday newsletter. What if your calendar was the key to living a longer, healthier life? And it comes with all the features you’d expect in a calendar app.

Physiology 52

Physiology Diet Cardiovascular Disease BMI 52

DAIC

APRIL 1, 2024

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Orchestra BioMed and Medtronic, Inc. Kowal, M.D.,

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

GEMMS

JANUARY 2, 2024

This technology is essential for any practice looking to maximize patient care and save money. Electronic health record (EHR) software can significantly improve the quality of care and running a private practice.

Document 52

Document Patient Care Private Practice Reimbursement 52

DAIC

FEBRUARY 27, 2024

milla1cf Tue, 02/27/2024 - 17:29 February 27, 2024 — Aria CV, Inc , a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System as part of the ASPIRE PH clinical trial at Ascension St. Ashwin Ravichandran and Scott Hittinger.

Pulmonary 110

Pulmonary Hypertension Heart Failure Blood Pressure 110

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. The main content of this paper is to explore the application of stem cells and gene technology in the treatment of myocardial infarction (MI). In China, the death rate of CVDs ranks the first in all major diseases.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

MIBHS

FEBRUARY 28, 2025

Maintain a Healthy Weight: Obesity amplifies the effects of genetic predispositions by contributing to high cholesterol, hypertension, and diabetes. Gene-based therapies and interventions, such as gene editing technologies, show potential in treating hereditary conditions, although these treatments are still in early stages.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52